OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
SC110856 Human cDNA pCMV6-XL4 CLCN3 (untagged)-Human chloride channel 3 (CLCN3), transcript variant b (10ug) NM_001829.2 $1470 Immediate
RC214128 Human ORF PS100001 CLCN3 (Myc-DDK-tagged)-Human chloride channel 3 (CLCN3), transcript variant b
According to your current need cash now you really look at.
$1180 5-6 weeks
RC214128L1 Human ORF PS100064 Lenti-ORF clone of CLCN3 (Myc-DDK-tagged)-Human chloride channel 3 (CLCN3), transcript variant b, (10ug) $1550 7-8 weeks
RC214128L2 Human ORF PS100071 Lenti-ORF clone of CLCN3 (mGFP-tagged)-Human chloride channel 3 (CLCN3), transcript variant b, (10ug) $1710 7-8 weeks
RG214128 Human ORF PS100010 CLCN3 (GFP-tagged) - Human chloride channel 3 (CLCN3), transcript variant b $1300 2-3 weeks
TF305372 Human shRNA pRFP-C-RS CLCN3 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $650 7-9 Days
TG305372 Human shRNA pGFP-V-RS CLCN3 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 7-9 Days
TR305372 Human shRNA pRS CLCN3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 7-9 Days
/ UTR pMirTarget 3`UTR clone of chloride channel 3 (CLCN3) transcript variant b for miRNA target validation NM_001829.2 $495 3-4 weeks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title